Yüklüyor......
Teprotumumab as a Novel Therapy for Thyroid-Associated Ophthalmopathy
Thyroid-associated ophthalmopathy (TAO) has remained a vexing and poorly managed autoimmune component of Graves’ disease where the tissues surrounding the eye and in the upper face become inflamed and undergo remodeling. This leads to substantial facial disfigurement while in its most severe forms,...
Kaydedildi:
| Yayımlandı: | Front Endocrinol (Lausanne) |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7774640/ https://ncbi.nlm.nih.gov/pubmed/33391187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.610337 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|